Colorectal Cancer: Updates in Screening, Treatment & Research
This activity consists of a recorded presentation from the "31st Annual National Clinical Conference" held in Bloomington, Minn., Oct. 17-19, 2022.
Rates of colorectal cancer (CRC) and CRC-related deaths have been steadily rising in adults younger than 66 years of age, most notably among individuals aged 20-39 years, and CRC remains both the fourth most common cancer and fourth leading cause of cancer-related death in the U.S. Both the U.S. Preventive Services Task Force and the American Cancer Society have recently lowered the recommended age for CRC screening to 45 years of age. Importantly, there have been recent and rapid advances in CRC research on surveillance and treatment, particularly for advanced disease. This activity discusses the current prevalence trends for CRC, new insight into risk factors, recommended screening approaches and modalities, treatment updates focused on tumor-specific molecular targets, and recent and emerging findings in CRC research and clinical trials.
This activity is provided by Optum Health Education.
There was no commercial support for this activity.
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
This activity is designed to meet the educational needs of case managers, nurses, pharmacists, pharmacy technicians, physicians, psychologists, social workers, dietitians, and other health care professionals who are interested in CRC.
At the end of this educational activity, participants should be able to:
- Recognize changing trends in the prevalence of CRC and discuss updates in identified risk factors and prevention strategies.
- Identify current CRC screening recommendations, including existing and emerging screening modalities and optimal screening approaches for groups of differing age and risk level.
- Discuss stage-related mainstays of CRC treatment and the evolving role of immunotherapy and targeted gene therapy.
- Describe current CRC research foci and examine data on emerging treatments and on-going clinical trials.
Richard D. Kim, MD
Professor of Oncology
University of South Florida College of Medicine;
Service Chief of Medical Gastrointestinal Oncology
Senior Member, Gastrointestinal Oncology Department
Moffitt Cancer Center
About the presenter
Richard Kim, MD, is a service chief of medical GI oncology/senior member in the gastrointestinal oncology department at Moffitt Cancer Center and professor of oncology at the University of South Florida College of Medicine. Dr. Kim received his medical degree from the University of Miami School of Medicine and completed a residency in internal medicine at the University of Illinois at Chicago. He pursued a postdoctoral fellowship in hematology and medical oncology at Yale University Comprehensive Cancer Center in New Haven, Conn. Before coming to Moffitt in 2010, Dr. Kim was an associate physician in gastrointestinal malignancies at the Cleveland Clinic Taussig Cancer Center and a clinical assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. Dr. Kim was named 2008 Teacher of the Year at the Cleveland Clinic and was selected for the 2008 Southwest Oncology Group Young Investigator Program and SWOG’s Intergroup Colon Task Force for junior faculty.
Dr. Kim’s clinical and research interests focus on gastrointestinal tumors and hepatobiliary and colon cancer. He is a principal investigator in multiple investigator-initiated and pharmaceutical phase I, II, III trials using immunotherapy and novel targeted agents.
Dr. Kim has published in many peer-reviewed journals including Lancet Oncology, British Journal of Cancer, JAMA Oncology, Clinical Cancer Research, Cancer and Journal of Clinical Oncology along with many book chapters. He has been an ad hoc editorial reviewer for many professional journals, including Journal of Clinical Oncology, Annals of Oncology, Cancer and Lancet Oncology. Dr Kim has spoken at over 50 national and international events, most recently ASCO Direct Highlights, the annual meeting of the Florida Academic Cancer Center Alliance, and the Spring Managed Care Forum in Orlando, Fla.
Elizabeth Albert, MD
Clinical Activity Manager
Optum Health Education
Eden Prairie, MN
Rebecca Gleason, RN, CCM
Optum Health Education
Eden Prairie, MN
Jennifer Malin, MD, PhD
Senior Vice President and Chief Medical Officer
Optum Health Solutions
Eden Prairie, MN
Tina Rydland, PharmD
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, OptumHealth Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
Dr. Richard Kim has indicated that he is a consultant for Roche; is on the advisory board for Ipsen, Roche, Servier, and Taiho; and is part of the speakers’ bureau for Eisai, Exelixis and Incyte.
The activity planners have no financial relationships to disclose.
Method for calculating CE credit
CE credit was calculated by the complexity of content.
In support of improving patient care, Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit designation statements
This activity was planned by and for the health care team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
The participant will be awarded up to 1.00 contact hour(s) of credit for attendance and completion of supplemental materials.
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
This activity is approved for 1.00 contact hour(s) ([0.100] CEU) in states that recognize ACPE.
Attending the full program will earn 1.00 contact hour(s).
Unique Activity Number(s): JA0007123-0000-23-087-H01-P/T
Optum Health Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
The Commission for Case Manager Certification has approved this program for a maximum of 1.00 clock hour(s) for Certified Case Managers (CCM).
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit=One CPEU).
If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour=1 CPEU).
RD's and DTRs are to select activity type 102 in their Activity Log. Performance indicator selection is at the learner's discretion.
Psychologists and social workers
Participants must have attended the entire Web-based activity and completed an evaluation to receive a certificate. Partial credit is not available.
Optum Health Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. Optum Health Education maintains responsibility for this program. 1.00 CE hour.
As a Jointly Accredited Organization, Optum Health Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Optum Health Education maintains responsibility for this course. Social workers completing this course receive 1.00 enduring continuing education credit.
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 CCMC - General - Case Managers
- 1.00 CDR - Dietitians
Prior to beginning this activity, please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
You must be logged into your account to participate in this activity. Get started by clicking the down arrow and then "Start" under “Webcast”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”